JSE may benefit from hopes of a Covid-19 treatment on Friday
US President Donald Trump has revealed plans for easing Covid-19 restrictions, while reports of a treatment have also led to improved sentiment
17 April 2020 - 07:04
The JSE could take its lead from firmer Asian markets on Friday morning, with markets benefiting from US plans to lift Covid-19 restrictions and reports of an effective treatment for the virus.
Remdesivir, a drug made by US biotech company Gilead Sciences, is reportedly helping some patients recover quickly from the pandemic...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.